Millennium Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Sell |
138,224
-1,972,550
| -93% | -$22.2M | ﹤0.01% | 2800 |
|
|
2025
Q1 | $9.65M | Sell |
2,110,774
-1,808,357
| -46% | -$8.26M | 0.01% | 1553 |
|
|
2024
Q4 | $22.1M | Sell |
3,919,131
-1,044,050
| -21% | -$5.89M | 0.01% | 1044 |
|
|
2024
Q3 | $24M | Buy |
4,963,181
+1,092,341
| +28% | +$5.29M | 0.01% | 981 |
|
|
2024
Q2 | $18.9M | Buy |
3,870,840
+3,256,410
| +530% | +$15.9M | 0.01% | 1102 |
|
|
2024
Q1 | $8.16M | Buy |
+614,430
| New | +$8.16M | ﹤0.01% | 1639 |
|
|
2023
Q4 | – | Sell |
-91,948
| Closed | -$1.22M | – | 4566 |
|
|
2023
Q3 | $1.22M | Buy |
+91,948
| New | +$1.22M | ﹤0.01% | 2800 |
|
|
2023
Q2 | – | Sell |
-28,679
| Closed | -$414K | – | 4788 |
|
|
2023
Q1 | $414K | Buy |
+28,679
| New | +$414K | ﹤0.01% | 3517 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5252 |
|
|
2022
Q3 | – | Sell |
-371,671
| Closed | -$5.68M | – | 5568 |
|
|
2022
Q2 | $5.68M | Buy |
+371,671
| New | +$5.68M | ﹤0.01% | 2046 |
|
|
2021
Q3 | – | Sell |
-409,994
| Closed | -$24.7M | – | 5500 |
|
|
2021
Q2 | $24.7M | Buy |
+409,994
| New | +$24.7M | 0.02% | 696 |
|